ID: ALA3706743

Max Phase: Preclinical

Molecular Formula: C39H41NO12

Molecular Weight: 715.75

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1c(O)c(CNCC(=O)OCc2ccccc2)c(C)c(C(=O)Oc2c(C)c(C)c(C(=O)Oc3c(C)c(C)c(C(=O)O)c(O)c3C)c(O)c2C)c1O

Standard InChI:  InChI=1S/C39H41NO12/c1-17-19(3)35(23(7)33(44)28(17)37(46)47)51-38(48)29-18(2)20(4)36(24(8)34(29)45)52-39(49)30-21(5)26(31(42)22(6)32(30)43)14-40-15-27(41)50-16-25-12-10-9-11-13-25/h9-13,40,42-45H,14-16H2,1-8H3,(H,46,47)

Standard InChI Key:  FWXIKWJMVSCPNM-UHFFFAOYSA-N

Associated Targets(Human)

Phospholipase A2 group IIA 1079 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Phospholipase A2 group 1B 720 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Phospholipase A2 group IIA 47 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Rattus norvegicus 775804 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 715.75Molecular Weight (Monoisotopic): 715.2629AlogP: 5.95#Rotatable Bonds: 11
Polar Surface Area: 209.15Molecular Species: ACIDHBA: 12HBD: 6
#RO5 Violations: 4HBA (Lipinski): 13HBD (Lipinski): 6#RO5 Violations (Lipinski): 4
CX Acidic pKa: 2.84CX Basic pKa: 5.88CX LogP: 8.31CX LogD: 7.27
Aromatic Rings: 4Heavy Atoms: 52QED Weighted: 0.08Np Likeness Score: 0.24

References

1. Teshirogi I, Matsutani S, Shirahase K, Fujii Y, Yoshida T, Tanaka K, Ohtani M..  (1996)  Synthesis and phospholipase A2 inhibitory activity of thielocin B3 derivatives.,  39  (26): [PMID:8978846] [10.1021/jm960437a]

Source